Top Markets
Coin of the day
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation

Mercury Biopharmaceutical Corporation

6932
Classifica tra le azioni #23452
Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury... Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury Biopharmaceutical Corporation is dedicated to creating innovative pharmaceutical solutions for medical conditions currently lacking adequate treatment options. A cornerstone of their strategy is the proprietary StackDose platform, an advanced drug development system designed to formulate novel medication delivery methods. This platform facilitates precisely timed drug release, targeted absorption at specific locations within the body, and flexible dosage modifications. The primary objective of StackDose is to significantly boost the bioavailability of active pharmaceutical ingredients, leading to a reduction in required drug dosages and fewer adverse effects. Their development pipeline currently addresses a variety of ailments, such as erectile dysfunction, pulmonary hypertension, sleep disturbances, benign prostatic hyperplasia, angina, migraines, hypertension, and pain management.
Prezzo delle azioni
$0.17616661
Ultima sincronizzazione: 2026-08-21
Capitalizzazione di mercato
$73.48M
Variazione (1 giorno)
0.18%
Variazione (1 anno)
-37.76%
Paese
TW
Scambia Mercury Biopharmaceutical Corporation (6932)

Categoria

Cronologia dei frazionamenti azionari per Mercury Biopharmaceutical Corporation (6932)
L’azione Mercury Biopharmaceutical Corporation (simbolo: 6932) ha subito un totale di 0 frazionamenti.
L’ultimo frazionamento è avvenuto il Aug 22, 2026.
Una quota di 6932 acquistata prima di Aug 22, 2026 equivale oggi a 0 quote di 6932.
Elenco dei frazionamenti azionari
Anno Frazionamento Moltiplicatore Moltiplicatore cumulativo
Non abbastanza dati per le date fornite.
Frazionamenti azionari di aziende simili o concorrenti